Bertelsmann Healthcare Investments Research
Investment Thesis
Bertelsmann Healthcare Investments (BHI) is a transatlantic, healthcare-focused investment firm launched inside Bertelsmann Investments, Bertelsmann's global venture arm (>$2bn AUM across ~500 companies and funds). BHI positions itself around "flexible capital, transatlantic reach, healthcare experts," backing entrepreneurs from day one and staying with them through early growth, with the flexibility to double or triple down in later rounds. Its 2026 thesis is organized around seven themes: the "systems of record" vs. "systems of action" shakeout in healthcare software, AI-driven labor productivity gains for providers/payors/life-sciences, the unbundling of insurance, the shift of healthcare payments to real time, an emerging "algorithmic medicine" stack for clinical decision support, automation of clinical R&D and trial operations, and new biopharma commercial models. Revenue cycle management and payment infrastructure have been a special focus since BHI's founding.
Sector Focus
BHI invests exclusively in healthcare technology, spanning digital health platforms (diagnostics AI, remote patient monitoring, primary care), health payments and RCM, med-tech/pharma compliance software, senior care technology, and AI-enabled clinical trial and biopharma R&D tooling. It is also part of Bertelsmann's broader healthcare alliance spanning learning, revenue cycle management, pharma tech, and logistics.
Stage Focus
BHI describes itself as partnering "from day one to early growth," and its own portfolio narrative (e.g., Onos) confirms a pattern of backing companies at pre-seed, doubling down at seed, and continuing into Series A. It also participates in later syndicate rounds (Series A/B) alongside other institutional investors (Teton, Take2, QuantHealth), and it selectively backs small-cap companies.
Check Size
No specific check-size range is published on the site; check sizes were not disclosed with confidence in any sourced material, so this field is left unset rather than estimated.
Lead Tendency
Mixed. BHI has led/anchored earliest rounds directly (Onos pre-seed/seed), but appears as a syndicate participant rather than lead investor in most disclosed growth-stage rounds (Flinn, Take2, Teton, QuantHealth).
Recent Activity
BHI has been actively deploying in 2025-2026: it participated in Teton.ai's $20M Series A (Sept 2025, led by Plural), backed Onos through pre-seed, seed, and into its Series A chapter, participated in Flinn's $20M raise for medtech/pharma compliance AI (Feb 2026), participated in Take2's $14M Series A for autonomous healthcare-recruiting agents (Feb 2026, led by Human Capital), and is an investor in QuantHealth's $45M Series B (Aug 2026, led by Qumra Capital). Portfolio company Phare Health was acquired by R1 RCM in October 2025.
Portfolio Highlights
Notable companies include Ataraxis (AI breast-cancer recurrence diagnostics), deepc (AI radiology platform, Munich), Doccla (virtual wards/remote patient monitoring), Paytient (health payment financing), Birches Health (gambling-addiction treatment), Teton.ai (predictive AI for senior care), Guardoc Health (AI clinical-documentation compliance for nurses), Patient21 (digital-physical primary care, Berlin), Flinn.ai (AI regulatory/quality compliance for medtech), Take2 (autonomous AI healthcare recruiting agents), Pi Health (AI-enabled oncology clinical trials), QuantHealth (AI clinical-trial simulation), Onos (clinical intelligence for health plans, starting in behavioral health), and Phare Health (AI inpatient coding/CDI, acquired by R1 RCM in 2025).
Team
- Thorsten Wirkes, Managing Director - Former McKinsey healthcare/payer consultant, early Oscar Health leader (Insurance Operations, payer-provider joint ventures), former COO at Covera Health; built and leads BHI.
- Tim Schneider, Partner - Founding partner who launched BHI's European office in Berlin; engineering and finance background, started career in PwC's global PE deals practice.
- Maximilian Boner, Europe Lead - Leads European investments (DACH, Nordics, UK); prior experience at Creandum, Activant Capital, and IK Partners.
- Agnes Uhr, Operating Partner - Nearly 20 years as an operator/advisor to European hospitals; previously at BFS health finance; law degree plus LL.M. from University of Auckland.
Decision Process
Partnership-style decision-making across a small, hands-on team (Managing Director, Partner, Europe Lead, Operating Partner) rather than a solo-GP or large investment-committee structure.
Founder Preferences
BHI looks for founders "obsessed with the problem they're solving," and emphasizes long-term, hands-on partnership - helping founders build, navigate, connect, and grow. Founder testimonials (Ataraxis, Doccla, Paytient, Onos, Birches Health) consistently cite deep healthcare-operating experience and network access as differentiators.
Geographic Focus
BHI actively invests across the U.S., Europe, and Israel, with teams on both sides of the Atlantic. It is often the first U.S. point of contact for European and Israeli founders, and helps U.S. companies expand globally.